Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

    NIH supports a consortium of centers refining human tissue models for infectious disease research and medical intervention testing to support regulatory acceptance; clinical trials are not allowed.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

    This grant funds innovative research to develop or improve broadly applicable models, materials, and methodologies for studying multiple body systems or diseases relevant to human health, excluding single disease or system studies.

    HHS-NIH11Forecasted Feb 16, 2028$500,000Forecasted

    Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

    Funding for innovative research to develop and improve animal models, related biological materials, and technologies for studies relevant to human health and disease, aligned with NIH-wide mission.

    HHS-NIH11Due Nov 16, 2026· 2d$275,000

    Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV AIDS Research (U42 Clinical Trial Not Allowed)

    This grant funds development and integration of human-based research methods and supports high-quality animal models to advance HIV/AIDS research while reducing animal use where possible.

    HHS-NIH11Forecasted Jan 25, 2027$2,725,311Forecasted

    National Biomedical Research Centers (P50 Clinical Trial Optional)

    This grant funds national biomedical research centers to develop innovative human-based research models and technologies that reduce animal use, supporting advanced science and national security across multiple NIH institutes.

    HHS-NIH11Forecasted Jan 25, 2027$11,405,967Forecasted

    Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

    NIH funds testing centers to evaluate the safety and efficacy of somatic cell genome editing for human disease therapies using preclinical models; clinical trials are not allowed.

    HHS-NIH11Forecasted Jan 25, 2028$900,000Forecasted